Neuren Pharmaceuticals Limited
NURPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $3 | $3 | $17 |
| Short-Term Investments | $294 | $219 | $211 | $211 |
| Receivables | $21 | $158 | $15 | $14 |
| Inventory | $0 | $15 | $0 | $0 |
| Other Curr. Assets | $0 | $4 | $0 | $0 |
| Total Curr. Assets | $320 | $399 | $228 | $247 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $10 | $0 | $1 |
| Other NC Assets | $11 | $0 | $0 | $0 |
| Total NC Assets | $11 | $10 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $331 | $410 | $228 | $248 |
| Liabilities | – | – | – | – |
| Payables | $7 | $1 | $4 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $4 | $37 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $41 | $0 | $42 |
| Total Curr. Liab. | $8 | $46 | $9 | $43 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8 | $46 | $9 | $43 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $128 | $165 | $176 | $173 |
| Retained Earnings | $195 | $180 | $46 | $38 |
| AOCI | $0 | $18 | -$3 | -$6 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $323 | $364 | $219 | $205 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $331 | $410 | $228 | $248 |
| Net Debt | -$6 | -$3 | -$3 | -$17 |